![Rainer Fischer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rainer Fischer
Directeur/Membre du Conseil chez Indiana Biosciences Research Institute
Postes actifs de Rainer Fischer
Sociétés | Poste | Début | Fin |
---|---|---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | 19/04/2019 | - | |
Directeur Général | 01/10/2017 | 19/04/2019 | |
Directeur Technique/Scientifique/R&D | 01/10/2016 | 19/04/2019 |
Historique de carrière de Rainer Fischer
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Commercial Services |
- Bourse
- Insiders
- Rainer Fischer
- Expérience